Overview
NUVB market data
Price History
NUVB price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for NUVB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price TargetBenzinga · Jul 23, 2026, 2:21 PM
Why Is Nuvation Bio Stock Gaining Monday?Benzinga · Jul 20, 2026, 3:44 PM
AMC Entertainment, IREN, Hut 8 And Other Big Stocks Moving Higher On MondayBenzinga · Jul 20, 2026, 2:08 PM
Nuvation Bio shares are trading higher after the company announced updated long-term follow-up data from the Phase 2 study of safusidenib in patients with chemotherapy- and radiotherapy-naïve grade 2 IDH1-mutant glioma.Benzinga · Jul 20, 2026, 2:06 PM
Nuvation Bio Announces Positive Updated Phase 2 Data And Expansion From Safusidenib Clinical Trial In Newly-Diagnosed Grade 2 Glioma Patients Outside The U.S.Benzinga · Jul 20, 2026, 12:09 PM
RBC Capital Maintains Outperform on Nuvation Bio, Lowers Price Target to $19Benzinga · Jul 7, 2026, 4:25 PM
Truist Securities Maintains Buy on Nuvation Bio, Raises Price Target to $13Benzinga · Jul 7, 2026, 12:35 PM
8-K filing — Nuvation Bio Inc. (NUVB)SEC EDGAR · Jul 6, 2026, 9:15 PM
UK's MHRA Validated Marketing Authorization Application Submitted By Nuvation Bio's Partner, Eisai, For Taletrectinib For Advanced ROS1-Positive Non-Small Cell Lung CancerBenzinga · Jun 29, 2026, 12:15 PM
H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market SessionBenzinga · Jun 25, 2026, 12:15 PM